Literature DB >> 17577715

The role of serum testosterone and TBI in the in-patient rehabilitation setting.

Timothy P Young1, Heather M Hoaglin, David T Burke.   

Abstract

OBJECTIVES: To explore the relationship between serum testosterone levels, age, length of stay, admission, discharge and changes in functional capacity over time among patients with traumatic brain injury treated in a rehabilitation hospital.
DESIGN: This study used a nonrandomized chart review of 54 males, consecutively admitted to a brain injury rehabilitation hospital.
METHODS: The charts of 54 males consecutively admitted to a brain injury rehabilitation unit between the periods of December 2004 and May 2005 were included in this study. Individuals were included in this study if they were 18 years of age or older, had suffered a traumatic brain injury, undergone admission and discharge, functional independence measure (FIM) testing and had received a serum testosterone level check within one to seven days from admission. MAIN OUTCOME AND
RESULTS: The main outcome measure of this study was the FIM changes over time, as compared with admission testosterone levels. Low serum testosterone levels on admission to the in-patient rehabilitation unit were associated with longer lengths of stay, lower average admission FIM scores, less improvement in FIM scores, and a lower FIM efficiency. Although not statistically significant, individuals presenting to our unit with low testosterone levels, on average, stayed 26 days longer than did those with normal levels. Age and the presence of multi-trauma did not appear to be factors associated with serum testosterone levels. Changes in discharge cognitive FIM scores between the two groups approached statistical significance (p = 0.06).
CONCLUSION: This pilot study suggests that testosterone levels may be important in the recovery of patients with traumatic brain injury, treated at an in-patient rehabilitation hospital.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17577715     DOI: 10.1080/02699050701210426

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  5 in total

Review 1.  What are critical outcome measures for patients receiving pituitary replacement following brain injury?

Authors:  Sorin G Beca; Walter M High; Brent E Masel; Kurt A Mossberg; Randall J Urban
Journal:  Pituitary       Date:  2012-03       Impact factor: 4.107

2.  Persistent Hypogonadotropic Hypogonadism in Men After Severe Traumatic Brain Injury: Temporal Hormone Profiles and Outcome Prediction.

Authors:  David J Barton; Raj G Kumar; Emily H McCullough; Gary Galang; Patricia M Arenth; Sarah L Berga; Amy K Wagner
Journal:  J Head Trauma Rehabil       Date:  2016 Jul-Aug       Impact factor: 2.710

3.  Estrogen Alleviates Sex-Dependent Differences in Lung Bacterial Clearance and Mortality Secondary to Bacterial Pneumonia after Traumatic Brain Injury.

Authors:  Jean-Francois Pittet; Parker J Hu; Jaideep Honavar; Angela P Brandon; Cilina A Evans; Rebekah Muthalaly; Qiang Ding; Brant M Wagener
Journal:  J Neurotrauma       Date:  2020-12-29       Impact factor: 5.269

4.  Detection of Growth Hormone Deficiency in Adults with Chronic Traumatic Brain Injury.

Authors:  Lisa A Kreber; Grace S Griesbach; Mark J Ashley
Journal:  J Neurotrauma       Date:  2015-11-19       Impact factor: 5.269

5.  Integration of Metabolomic and Clinical Data Improves the Prediction of Intensive Care Unit Length of Stay Following Major Traumatic Injury.

Authors:  Animesh Acharjee; Jon Hazeldine; Alina Bazarova; Lavanya Deenadayalu; Jinkang Zhang; Conor Bentley; Dominic Russ; Janet M Lord; Georgios V Gkoutos; Stephen P Young; Mark A Foster
Journal:  Metabolites       Date:  2021-12-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.